Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevance.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbalip.2010.05.014PMID 20595010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A DIRECT ROLE FOR SECRETORY PHOSPHOLIPASE A2 AND LYSOPHOSPHATIDYLCHOLINE IN THE MEDIATION OF LPS-INDUCED GASTRIC INJURY

  2010cited by this paper
• Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes

  2010cited by this paper
• Intestinal mucosal barrier function in health and disease

  2009cited by this paper
• Naproxen-PC: A GI safe and highly effective anti-inflammatory

  2009cited by this paper
• Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis

  2009cited by this paper
• Immune responses to the microbiota at the intestinal mucosal surface.

  2009cited by this paper
• Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease

  2009cited by this paper
• Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease.

  2009cited by this paper
• Modulation of peritoneal macrophage activity by the saturation state of the fatty acid moiety of phosphatidylcholine.

  2009cited by this paper
• Inflammatory Disease Processes and Interactions with Nutrition

  2009cited by this paper
• P244 - Impact of biliary and nutritional lack of phospholipids in a colitis mouse model

  2009cited by this paper
• Micellar lipid composition profoundly affects LXR‐dependent cholesterol transport across CaCo2 cells

  2009cited by this paper
• Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein.

  2009cited by this paper
• Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

  2009cited by this paper
• Liver diseases related to MDR3 (ABCB4) gene deficiency.

  2009cited by this paper
• Lysophospholipids: their generation, physiological role and detection. Are they important disease markers?

  2009cited by this paper
• Phosphatidylcholine reverses ethanol-induced increase in transepithelial endotoxin permeability and abolishes transepithelial leukocyte activation.

  2009cited by this paper
• Epithelial Tight Junctions in Intestinal Inflammation

  2009cited by this paper
• TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells

  2009cited by this paper
• The gut microbiota in inflammatory bowel disease.

  2009cited by this paper
• Curvature generation and pressure profile modulation in membrane by lysolipids: insights from coarse-grained simulations.

  2009cited by this paper
• The trefoil factor family – small peptides with multiple functionalities

  2009cited by this paper
• Role of lipids in killing mycobacteria by macrophages: evidence for NF‐κB‐dependent and ‐independent killing induced by different lipids

  2009cited by this paper
• Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis

  2009cited by this paper
• Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

  2008cited by this paper
• Pouch-ouch

  2008cited by this paper
• Role of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens

  2008cited by this paper
• Lipid signalling in disease

  2008cited by this paper
• Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery.

  2008cited by this paper
• The mucosal immune system at the gastrointestinal barrier.

  2008cited by this paper
• Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes

  2008cited by this paper
• The pathogenic role of intestinal flora in IBD and colon cancer.

  2008cited by this paper
• Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial.

  2008cited by this paper
• The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

  2008cited by this paper
• Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties

  2008cited by this paper
• ORAL PHOSPHATIDYLCHOLINE PRESERVES THE GASTROINTESTINAL MUCOSAL BARRIER DURING LPS-INDUCED INFLAMMATION

  2008cited by this paper
• Clinical trial: comparison of ibuprofen‐phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients

  2008cited by this paper
• DPPC regulates COX-2 expression in monocytes via phosphorylation of CREB.

  2008cited by this paper
• Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity

  2008cited by this paper
• Anti-Inflammatory Action of a Phosphatidylcholine, Phosphatidylethanolamine and N-Acylphosphatidylethanolamine-Enriched Diet in Carrageenan-Induced Pleurisy

  2008cited by this paper
• Immune-non immune networks in intestinal inflammation.

  2008cited by this paper
• PATHOPHYSIOLOGY OF LPS-INDUCED GASTROINTESTINAL INJURY IN THE RAT: ROLE OF SECRETORY PHOSPHOLIPASE A2

  2007cited by this paper
• Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production

  2007cited by this paper
• HYDROPHOBICITY OF MUCOSAL SURFACE AND ITS RELATIONSHIP TO GUT BARRIER FUNCTION

  2007cited by this paper
• Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats

  2007cited by this paper
• Defensins and other antimicrobial peptides in inflammatory bowel disease

  2007cited by this paper
• Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis

  2007cited by this paper
• Immunoregulatory role of intestinal surfactant-like particles during Salmonella typhimurium infection

  2007cited by this paper
• The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis

  2007cited by this paper
• Phospholipids as implant coatings

  2007cited by this paper
• Inflammatory bowel disease: Progress and current concepts of etiopathogenesis

  2007cited by this paper
• Intestinal alkaline phosphatase: selective endocytosis from the enterocyte brush border during fat absorption.

  2007cited by this paper
• Anti-inflammatory Effects of Phosphatidylcholine*

  2007cited by this paper
• Indomethacin Enhances Bile Salt Detergent Activity: Relevance for NSAIDs-Induced Gastrointestinal Mucosal Injury

  2006cited by this paper
• Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry.

  2006cited by this paper
• The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.

  2006cited by this paper
• Ecological and evolutionary forces shaping microbial diversity in the human intestine.

  2006cited by this paper
• Histologic Response to Injected Phosphatidylcholine in Fat Tissue: Experimental Study in a New Rabbit Model

  2006cited by this paper
• Alterations in the Composition of the Supramucosal Defense Barrier in Relation to Disease Severity of Ulcerative Colitis

  2006cited by this paper
• Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury.

  2006cited by this paper
• Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux.

  2006cited by this paper
• Assessment and prevention of gastrointestinal toxicity of non‐steroidal anti‐inflammatory drugs

  2006cited by this paper
• NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes

  2006cited by this paper
• Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt‐induced ileal mucosa injury

  2006cited by this paper
• Biochemical and Molecular Actions of Nutrients Uptake of Micellar Long-Chain Fatty Acid and sn2-Monoacylglycerol into Human Intestinal Caco-2 Cells Exhibits Characteristics of Protein-Mediated Transport 1

  2005cited by this paper
• Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease?

  2005cited by this paper
• Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis

  2005cited by this paper
• Host-Bacterial Mutualism in the Human Intestine

  2005cited by this paper
• Surfactant phospholipid DPPC downregulates monocyte respiratory burst via modulation of PKC.

  2005cited by this paper
• Relationship between fluidity and ionic permeability of bilayers from natural mixtures of phospholipids

  2005cited by this paper
• Give lipids a START: the StAR-related lipid transfer (START) domain in mammals

  2005cited by this paper
• Immunity, Inflammation, and Allergy in the Gut

  2005cited by this paper
• Epithelial barrier function in vivo is sustained despite gaps in epithelial layers.

  2005cited by this paper
• Effects of Prostaglandin E1 and E2 Analogues on Mucosal Injury-Induced, and on Bacterial Translocation Promoted by, Experimental Intestinal Obstruction

  2004cited by this paper
• Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray‐tandem mass spectrometry

  2004cited by this paper
• Evidence of luminal phosphatidylcholine secretion in rat ileum.

  2004cited by this paper
• Sphingolipids in inflammation: roles and implications.

  2004cited by this paper
• Therapeutic effects of lysophosphatidylcholine in experimental sepsis

  2004cited by this paper
• Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.

  2004cited by this paper
• Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane

  2004cited by this paper
• TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells.

  2004cited by this paper
• The complex life of simple sphingolipids

  2004cited by this paper
• Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation.

  2003cited by this paper
• Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor.

  2003cited by this paper
• Regulation of transbilayer plasma membrane phospholipid asymmetry Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.R200019-JLR200

  2003cited by this paper
• Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease

  2003cited by this paper
• Lipid rafts in epithelial brush borders: atypical membrane microdomains with specialized functions.

  2003cited by this paper
• Phosphatidylcholine-enriched diet prevents gallstone formation in mice susceptible to cholelithiasis Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300180-JLR200

  2003cited by this paper
• Dynamic tension spectroscopy and strength of biomembranes.

  2003cited by this paper
• Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria

  2003cited by this paper
• Location is everything: lipid rafts and immune cell signaling.

  2003cited by this paper
• Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation

  2003cited by this paper
• Surface‐active phospholipid: a Pandora’s box of clinical applications. Part II. Barrier and lubricating properties

  2002cited by this paper
• Role of mucins in inflammatory bowel disease: important lessons from experimental models

  2002cited by this paper
• Lipopolysaccharide-Induced Gastrointestinal Injury in Rats: Role of Surface Hydrophobicity and Bile Salts

  2002cited by this paper
• Surface‐active phospholipid: a Pandora’s box of clinical applications. Part I. The lung and air spaces

  2002cited by this paper
• Lisofylline and Lysophospholipids Ameliorate Experimental Colitis in Rats

  2002cited by this paper
• Changes in the chemical composition of surfactant-like particles secreted by rat small intestine in response to different dietary fats

  2002cited by this paper
• Mucosal flora in inflammatory bowel disease.

  2002cited by this paper
• Cholesterol, lipid rafts, and disease.

  2002cited by this paper

• Yacon (Smallanthus sonchifolius) Root Increases Bowel Movement Frequency in Healthy Adults via Modulating Gut Microbiota and Intestinal Metabolites: A Pilot Study

  2025cites this paper
• Associations of alcohol with the human gut microbiome and prospective health outcomes in the FINRISK 2002 cohort

  2025cites this paper
• Therapeutic liposomes synergize with active molecules to enhance targeted therapy

  2025cites this paper
• Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Scopolamine-Induced Cognitive Impairment Through Metabolic Modulation

  2025cites this paper
• Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis

  2024cites this paper
• A Novel Multiple-Network Analysis Integrating Metabolomics and Pharmacology for Mechanism Study of Medicine: A Case Study of CDD-2101 Against Constipation

  2024cites this paper
• Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease

  2024cites this paper
• Activity-Based Protein Profiling Identifies Klebsiella pneumoniae Serine Hydrolases with Potential Roles in Host-Pathogen Interactions

  2024cites this paper
• Donor-recipient intermicrobial interactions impact transfer of subspecies and fecal microbiota transplantation outcome.

  2024cites this paper
• Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease

  2024cites this paper
• Based on metabolomics analysis: metabolic mechanism of intestinal tract of Scylla paramamosain under low-salt saline-alkali water aquaculture environment

  2024cites this paper
• Aspirin Interacts with Cholesterol-Containing Membranes in a pH-Dependent Manner

  2023cites this paper
• New Meloxicam Derivatives—Synthesis and Interaction with Phospholipid Bilayers Measured by Differential Scanning Calorimetry and Fluorescence Spectroscopy

  2023cites this paper
• Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice

  2023cites this paper
• Investigating host-gut microbial relationship in Penaeus monodon upon exposure to Vibrio harveyi

  2023cites this paper
• Total Lipid Extracts of Honeybee Drone Larvae Are Modulated by Extraction Temperature and Display Consistent Anti-Inflammatory Potential

  2023cites this paper
• Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea

  2022cites this paper
• 'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases.

  2021cites this paper
• Long term exposure of human gut microbiota with high and low emulsifier sensitivity to soy lecithin in M-SHIME model

  2021cites this paper
• Fundamentals of Membrane Lipid Replacement: A Natural Medicine Approach to Repairing Cellular Membranes and Reducing Fatigue, Pain, and Other Symptoms While Restoring Function in Chronic Illnesses and Aging

  2021cites this paper
• Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach

  2021cites this paper
• Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug–Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models

  2021cites this paper
• Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis.

  2020cites this paper
• Dietary Emulsifiers Alter Composition and Activity of the Human Gut Microbiota in vitro, Irrespective of Chemical or Natural Emulsifier Origin

  2020cites this paper
• Physicochemical and biopharmaceutical characterization of novel Matrix-Liposomes.

  2020cites this paper
• Construction of a sensitive cascade catalytic method for measurements of plasma phosphatidylcholine

  2020cites this paper
• Study of Differential Serum Metabolites in Patients with Adenomatous Polyps of Colon and Yang-Deficiency Constitution Based on Ultra-Performance Liquid Chromatography-Mass Spectrometry

  2019cites this paper
• Pancreatic and mucosal enzymes in choline phospholipid digestion.

  2019cites this paper
• Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis.

  2019cites this paper
• Bioactive Lipids

  2019cites this paper
• Advance in food-derived phospholipids: Sources, molecular species and structure as well as their biological activities

  2018cites this paper
• Phospholipolysis Caused by Different Types of Bacterial Phospholipases During Cold Storage of Bovine Raw Milk Is Prevented by N2 Gas Flushing

  2018cites this paper
• Technological development of microemulsions with perspectives for pain treatment: a patent review

  2018cites this paper
• Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues.

  2017cites this paper
• Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications

  2017cites this paper
• Assessing gastric toxicity of xanthone derivatives of anti-inflammatory activity using simulation and experimental approaches.

  2017cites this paper
• The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model

  2017cites this paper
• Resolution of inflammation in inflammatory bowel disease.

  2017cites this paper
• Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis.

  2017cites this paper
• In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy.

  2017cites this paper
• Neural regulation of innate and adaptive immunity in the gut

  2017cites this paper
• Metabolomic analysis of glycerophospholipid signatures of inflammation treated with non-steroidal anti-inflammatory drugs-induced-RAW264.7 cells using (1)H NMR and U-HPLC/Q-TOF-MS.

  2016cites this paper
• Effects of lactadherin on plasma D-lactic acid and small intestinal MUC2 and claudin-1 expression levels in rats with rotavirus-induced diarrhea.

  2016cites this paper
• Dietary Reference Values for choline

  2016cites this paper
• Therapeutic applications of reconstituted HDL: When structure meets function.

  2016cites this paper
• Chronisch-entzündliche Darmerkrankungen

  2016cites this paper
• Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment*

  2015cites this paper
• Modulation of colon carcinogenesis by dietary ω-6/ω-3 fatty acid ratios : a chemopreventive strategy?

  2015cites this paper
• Milk and Dairy Polar Lipids: Occurrence, Purification, and Nutritional and Technological Properties

  2015cites this paper
• Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile-associated polymorphonuclear neutrophil activation.

  2015cites this paper
• Relevance of dietary glycerophospholipids and sphingolipids to human health.

  2015cites this paper
• Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.

  2015cites this paper
• Lipid Replacement Therapy: a natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function.

  2014cites this paper
• Protective effects of citicoline on TNBS-induced experimental colitis in rats.

  2014cites this paper
• Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin

  2014influential citation
• Chronisch-entzündliche Darmerkrankungen

  2014cites this paper
• Aktuelle Diagnostik und Therapie der Colitis ulcerosa

  2014cites this paper
• Gastrointestinal Mucosal Defense System

  2014cites this paper
• NMR-Based Metabonomic Studies on Stomach Heat and Cold Syndromes and Intervention Effects of the Corresponding Formulas

  2014cites this paper
• Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro.

  2014cites this paper
• Milk Fat Globule Membrane Material: Isolation Techniques, Health-Beneficial Properties, and Potential Applications

  2014cites this paper
• Original Article Protective effects of citicoline on TNBS-induced experimental colitis in rats

  2014cites this paper
• CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis.

  2013cites this paper
• Identification of the Molecular Mechanisms underlying the Gastrointestinal Toxicity of the Immunosuppressants Mycophenolate Mofetil and Enteric-coated Mycophenolate Sodium using a Proteo-Metabolomic Approach

  2013influential citation
• Preventive and therapeutic possibilities for inhibition of the inflammatory consequences of experimental colitis

  2012cites this paper
• [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease].

  2012cites this paper
• Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

  2012cites this paper
• Different Roles for Lactococcal Aggregation Factor and Mucin Binding Protein in Adhesion to Gastrointestinal Mucosa

  2012cites this paper
• Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatography-imaging technique.

  2012cites this paper
• Cholinergic signalling in gut immunity.

  2012cites this paper
• Liposomes as drug delivery system in mitochondrial targeting

  2012cites this paper
• Health effects of dietary phospholipids

  2012cites this paper
• Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

  2012cites this paper
• Dietary Phosphatidylcholine Supplementation Attenuates Inflammatory Mucosal Damage in a Rat Model of Experimental Colitis

  2012cites this paper
• Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.

  2012cites this paper
• Dietary triacylglycerol structure and its role in infant nutrition.

  2011cites this paper
• Physiological functions and clinical implications of sphingolipids in the gut

  2011cites this paper
• Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-

  2011cites this paper
• Comparison of lysophospholipid levels in rat feces with those in a standard chow.

  2011cites this paper
• Comparative model studies of gastric toxicity of nonsteroidal anti-inflammatory drugs.

  2011cites this paper
• Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation

  2010cites this paper
• Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis – a review of three clinical trials

  2010cites this paper